Biora Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
125.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.87
|
-0.75
|
1.12
|
59.89%
|
|
2022-06-30
|
-3.00
|
-0.75
|
2.25
|
75.00%
|
|
2022-03-31
|
-3.12
|
-2.00
|
1.12
|
35.90%
|
|
2021-12-31
|
-4.00
|
-14.00
|
-10.00
|
-250.00%
|
|
2021-09-30
|
-11.17
|
-11.50
|
-0.33
|
-2.95%
|
|
2021-06-30
|
-20.17
|
-30.75
|
-10.58
|
-52.45%
|
|
2021-03-31
|
-20.30
|
-14.00
|
6.30
|
31.03%
|
|
2020-12-31
|
-20.55
|
-38.25
|
-17.70
|
-86.13%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.50
|
|
2021-12-31
|
-70.25
|
|
2020-12-31
|
-50.44
|